GHA
BIIB icon

Garcia Hamilton & Associates’s Biogen BIIB Stock Holding History

Garcia Hamilton & Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-663
Closed -$208K – 7
2017
Q3 		$208K Sell
663
-679
-51% -$201K 0.54% 43
2017
Q2 		$364K Sell
1,342
-892
-40% -$236K 0.5% 55
2017
Q1 		$606K Sell
2,234
-1,835
-45% -$519K 0.54% 56
2016
Q4 		$1.15M Sell
4,069
-347
-8% -$103K 0.67% 52
2016
Q3 		$1.38M Buy
4,416
+40
+0.9% +$11.8K 0.81% 49
2016
Q2 		$1.06M Sell
4,376
-175
-4% -$46.1K 0.64% 58
2016
Q1 		$1.19M Sell
4,551
-8
-0.2% -$2.11K 0.69% 57
2015
Q4 		$1.4M Buy
4,559
+83
+2% +$23.9K 0.82% 50
2015
Q3 		$1.31M Sell
4,476
-3
-0.1% -$991 0.8% 49
2015
Q2 		$1.81M Buy
+4,479
New +$1.8M 1% 45

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Garcia Hamilton & Associates's BIIB Position: Q4 2017 in Review

Garcia Hamilton & Associates sold out of Biogen (BIIB) in Q4 2017, closing a stake of 663 shares — an estimated $208K sold.

Garcia Hamilton & Associates first reported a position in BIIB in Q2 2015 and held it in 10 quarters. The position peaked at $1.81M in Q2 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Garcia Hamilton & Associates reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 663 Biogen shares in Q4 2017, an estimated $208K.
  • Garcia Hamilton & Associates first reported a position in Biogen in Q2 2015 and held it in 10 quarters.
  • Garcia Hamilton & Associates's Biogen position peaked at $1.81M in Q2 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.